168 related articles for article (PubMed ID: 18289000)
1. Targeting leukocytes in immune glomerular diseases.
Kitching AR; Holdsworth SR; Hickey MJ
Curr Med Chem; 2008; 15(5):448-58. PubMed ID: 18289000
[TBL] [Abstract][Full Text] [Related]
2. Endogenous IL-13 limits humoral responses and injury in experimental glomerulonephritis but does not regulate Th1 cell-mediated crescentic glomerulonephritis.
Kitching AR; Turner AL; Wilson GR; Edgtton KL; Tipping PG; Holdsworth SR
J Am Soc Nephrol; 2004 Sep; 15(9):2373-82. PubMed ID: 15339986
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of glomerular damage in glomerulonephritis.
Couser WG
Nephrol Dial Transplant; 1998; 13 Suppl 1():10-5. PubMed ID: 9507491
[TBL] [Abstract][Full Text] [Related]
4. Myeloid cell-mediated renal injury in rapidly progressive glomerulonephritis depends upon spleen tyrosine kinase.
Ryan J; Ma FY; Han Y; Ozols E; Kanellis J; Tesch GH; Nikolic-Paterson DJ
J Pathol; 2016 Jan; 238(1):10-20. PubMed ID: 26251216
[TBL] [Abstract][Full Text] [Related]
5. Review: T helper 17 cells: their role in glomerulonephritis.
Ooi JD; Kitching AR; Holdsworth SR
Nephrology (Carlton); 2010 Aug; 15(5):513-21. PubMed ID: 20649870
[TBL] [Abstract][Full Text] [Related]
6. T cells in crescentic glomerulonephritis.
Tipping PG; Holdsworth SR
J Am Soc Nephrol; 2006 May; 17(5):1253-63. PubMed ID: 16624930
[TBL] [Abstract][Full Text] [Related]
7. [Pathogenesis of immune glomerulonephritis].
Rougier JP; Ronco P
Rev Prat; 2003 Nov; 53(18):1998-2004. PubMed ID: 15008213
[TBL] [Abstract][Full Text] [Related]
8. Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis.
Ruth AJ; Kitching AR; Kwan RY; Odobasic D; Ooi JD; Timoshanko JR; Hickey MJ; Holdsworth SR
J Am Soc Nephrol; 2006 Jul; 17(7):1940-9. PubMed ID: 16769746
[TBL] [Abstract][Full Text] [Related]
9. Myeloperoxidase (MPO)-specific CD4+ T cells contribute to MPO-anti-neutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis.
Gan PY; Holdsworth SR; Kitching AR; Ooi JD
Cell Immunol; 2013 Mar; 282(1):21-7. PubMed ID: 23665205
[TBL] [Abstract][Full Text] [Related]
10. The Changing Landscape of Renal Inflammation.
Ernandez T; Mayadas TN
Trends Mol Med; 2016 Feb; 22(2):151-163. PubMed ID: 26778189
[TBL] [Abstract][Full Text] [Related]
11. FcγRIIB regulates T-cell autoreactivity, ANCA production, and neutrophil activation to suppress anti-myeloperoxidase glomerulonephritis.
Ooi JD; Gan PY; Chen T; Eggenhuizen PJ; Chang J; Alikhan MA; Odobasic D; Holdsworth SR; Kitching AR
Kidney Int; 2014 Dec; 86(6):1140-9. PubMed ID: 24869670
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-17RA Promotes Humoral Responses and Glomerular Injury in Experimental Rapidly Progressive Glomerulonephritis.
Ghali JR; O'Sullivan KM; Eggenhuizen PJ; Holdsworth SR; Kitching AR
Nephron; 2017; 135(3):207-223. PubMed ID: 27941331
[TBL] [Abstract][Full Text] [Related]
13. Infection and glomerulonephritis.
Naicker S; Fabian J; Naidoo S; Wadee S; Paget G; Goetsch S
Semin Immunopathol; 2007 Nov; 29(4):397-414. PubMed ID: 17846774
[TBL] [Abstract][Full Text] [Related]
14. [Role of monoclonal antibodies in the treatment of immune-mediated kidney disease: the state of the art].
Cravedi P
G Ital Nefrol; 2012; 29(3):274-82; discussion 292. PubMed ID: 22718450
[TBL] [Abstract][Full Text] [Related]
15. Treatment of glomerulonephritis: will we ever have options other than steroids and cytotoxics?
Javaid B; Quigg RJ
Kidney Int; 2005 May; 67(5):1692-703. PubMed ID: 15840015
[TBL] [Abstract][Full Text] [Related]
16. Th17 cells promote autoimmune anti-myeloperoxidase glomerulonephritis.
Gan PY; Steinmetz OM; Tan DS; O'Sullivan KM; Ooi JD; Iwakura Y; Kitching AR; Holdsworth SR
J Am Soc Nephrol; 2010 Jun; 21(6):925-31. PubMed ID: 20299361
[TBL] [Abstract][Full Text] [Related]
17. Plasticity and heterogeneity of Th17 in immune-mediated kidney diseases.
Krebs CF; Panzer U
J Autoimmun; 2018 Feb; 87():61-68. PubMed ID: 29275837
[TBL] [Abstract][Full Text] [Related]
18. New insights into circulating cell-endothelium interactions and their significance for glomerular pathophysiology.
Noris M; Remuzzi G
Am J Kidney Dis; 1995 Sep; 26(3):541-8. PubMed ID: 7645567
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody analysis of glomerular hypercellularity in human glomerulonephritis.
Hooke DH; Hancock WW; Gee DC; Kraft N; Atkins RC
Clin Nephrol; 1984 Oct; 22(4):163-8. PubMed ID: 6391767
[TBL] [Abstract][Full Text] [Related]
20. T helper type 17 cells in immune-mediated glomerular disease.
Krebs CF; Schmidt T; Riedel JH; Panzer U
Nat Rev Nephrol; 2017 Oct; 13(10):647-659. PubMed ID: 28781371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
